Asia-Pacific is expected to be the fastest-growing region in the intestinal ischemia market during the forecast period, with a projected CAGR 8.4%, driven by improving healthcare access, rising healthcare expenditure, and increasing disease burden
The parenteral segment dominated the largest market revenue share of 61.5% in 2025, driven by its effectiveness in emergency and acute care settings
7 Views